A significant shift in Canadian drug policy has happened, as the government permit the legalization of psilocybin hallucinogens for therapeutic treatment. Before this, these substances were severely restricted, but a increasing body of evidence suggests they could offer relief for psychological conditions like depression. The new policy represents